Piedmont Investment Advisors’s Hologic HOLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-23,376
Closed -$820K 308
2020
Q1
$820K Buy
23,376
+2,394
+11% +$114K 0.03% 334
2019
Q4
$1.09M Buy
20,982
+890
+4% +$44.3K 0.04% 318
2019
Q3
$1.01M Buy
20,092
+558
+3% +$27.5K 0.04% 313
2019
Q2
$938K Buy
19,534
+15,193
+350% +$703K 0.04% 349
2019
Q1
$210K Buy
+4,341
New +$196K 0.01% 1048
2018
Q3
Sell
-3,196
Closed -$127K 1593
2018
Q2
$127K Buy
+3,196
New +$123K 0.01% 1024
2017
Q1
Sell
-786
Closed -$31.5K 509
2016
Q4
$31.5K Buy
786
+782
+19,550% +$30.2K ﹤0.01% 507
2016
Q3
$155 Hold
4
﹤0.01% 623
2016
Q2
$138 Buy
+4
New +$139 ﹤0.01% 596

Other funds holding HOLX

Piedmont Investment Advisors's HOLX Position: Q2 2020 in Review

Piedmont Investment Advisors sold out of Hologic (HOLX) in Q2 2020, closing a stake of 23,376 shares — an estimated $820K sold.

Piedmont Investment Advisors first reported a position in HOLX in Q2 2016 and held it in 9 quarters. The position peaked at $1.09M in Q4 2019. 522 funds tracked by Wall St. Rank hold HOLX as of Q2 2020.

  • Piedmont Investment Advisors reported no remaining Hologic position as of Q2 2020 after selling out during the quarter.
  • Piedmont Investment Advisors sold 23,376 Hologic shares in Q2 2020, an estimated $820K.
  • Piedmont Investment Advisors first reported a position in Hologic in Q2 2016 and held it in 9 quarters.
  • Piedmont Investment Advisors's Hologic position peaked at $1.09M in Q4 2019.
  • 522 funds tracked by Wall St. Rank held Hologic as of Q2 2020.

Based on Piedmont Investment Advisors's 13F filing for Q2 2020.